与T1期结直肠癌淋巴结转移相关的微小RNA特征
研究从癌症基因组图谱中筛选出5种微小RNA(MIR32、MIR181B、MIR193B、MIR195、MIR411),其在伴或不伴淋巴结转移的T1和T2期结直肠癌中表达有显著变化。该5种微小RNA特征在T1或T2期癌中识别淋巴结侵犯的AUROC为0.84,在两个T1期癌队列中验证AUROC分别为0.83和0.74,在未治疗患者活检样本中为0.77。该特征识别高风险T1期结直肠癌的准确度高于目前使用的病理特征。
要点
- 5种微小RNA特征在T1或T2期结直肠癌中识别淋巴结侵犯的AUROC为0.84。
- 在T1期癌队列1和队列2中验证,AUROC分别为0.83和0.74。
- 在未治疗患者活检样本中识别淋巴结转移的AUROC为0.77。
核心结论
- 5种微小RNA特征识别高风险T1期结直肠癌的准确度高于目前使用的病理特征。
研究设计与样本
- 从癌症基因组图谱收集数据,筛选出5种在伴或不伴淋巴结转移的T1和T2期结直肠癌中表达有显著变化的微小RNA(MIR32、MIR181B、MIR193B、MIR195、MIR411)。
- 在两个T1期癌患者队列中以组织学发现为参考进行验证,并分析未治疗患者的活检样本。
主要发现
- 5种微小RNA在T1或T2期癌中识别淋巴结侵犯的AUROC为0.84。
- 5种微小RNA特征在队列1中识别T1期癌淋巴结侵犯的AUROC为0.83,在队列2中为0.74。
- 在未治疗患者活检样本中,5种微小RNA特征识别淋巴结转移的AUROC为0.77。
关键数值与推荐
- 5种微小RNA特征识别T1或T2期癌淋巴结侵犯的AUROC为0.84。
- 队列1中识别T1期癌淋巴结侵犯的AUROC为0.83,队列2中为0.74。
- 未治疗患者活检样本中识别淋巴结转移的AUROC为0.77。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most T1 colorectal cancers treated by radical surgery can now be cured by endoscopic submucosal dissection. Although 70%-80% of T1 colorectal cancers are classified as high risk, <16% of these patients actually have lymph node metastases. Biomarkers are needed to identify patients with T1 cancers with the highest risk of metastasis, to prevent unnecessary radical surgery. We collected data from The Cancer Genome Atlas and identified 5 microRNAs (MIR32, MIR181B, MIR193B, MIR195, and MIR411) with significant changes in expression in T1 and T2 colorectal cancers with vs without lymph node metastases. Levels of the 5 microRNAs identified patients with lymph node invasion by T1 or T2 cancers with an area under the receiver operating characteristic curve (AUROC) value of 0.84. We validated these findings in 2 cohorts of patients with T1 cancers, using findings from histology as the reference. The 5-microRNA signature identified T1 cancers with lymph node invasion in cohort 1 with an AUROC value of 0.83, and in cohort 2 with an AUROC value of 0.74. When we analyzed biopsy samples from untreated patients, the 5-microRNA signature identified cancers with lymph node metastases with an AUROC value of 0.77. The 5-microRNA therefore identifies high-risk T1 colorectal cancers with a greater degree of accuracy than currently used pathologic features.
引用
- Ozawa T, Kandimalla R, Gao F, et al. A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes. Gastroenterology. 2017. PMID: 29199088. doi:10.1053/j.gastro.2017.11.275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。